Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,134,842
+$230,854 QoQ
Shares Held
1,820
+55.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#623
of 1,329 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Dec 31, 2021CallValue
$0
CallShares
0
PutValue
$6,315,200
PutShares
10,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CSS LLC/IL holds $23,787,576 across 16 Biotechnology names. REGN ranks #4 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
152,289 | $12,074,994 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
29,041 | $6,998,009 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
22,580 | $1,292,027 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,820 | $1,134,842 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
6,520 | $510,320 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
8,470 | $481,180 | |
| 7 | EXEL |
Exelixis, Inc.
|
8,709 | $473,856 | |
| 8 | INCY |
Incyte Corp
|
3,856 | $437,116 |
All Filings in REGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,134,842 | 1,820 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $903,988 | 1,170 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $262,435 | 340 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $378,000 | 720 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $431,276 | 680 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $434,521 | 610 | Shares | Sole | 2025-02-18 | |
| 2023-03-31 | $246,501 | 300 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $360,745 | 500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $413,322 | 600 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $354,678 | 600 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $419,052 | 600 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,315,200 | 10,000 | Put | Sole | 2022-02-14 | |
| 2021-12-31 | $505,216 | 800 | Shares | Sole | 2022-02-14 | |
| 2020-09-30 | $4,926,064 | 8,800 | Put | Sole | 2020-11-16 | |
| 2020-09-30 | $315,715 | 564 | Shares | Sole | 2020-11-16 | |
| 2020-09-30 | $2,127,164 | 3,800 | Call | Sole | 2020-11-16 | |
| 2020-06-30 | $3,617,170 | 5,800 | Put | Sole | 2020-08-14 | |
| 2020-06-30 | $560,661 | 899 | Shares | Sole | 2020-08-14 | |
| 2020-06-30 | $1,122,570 | 1,800 | Call | Sole | 2020-08-14 | |
| 2020-03-31 | $1,953,160 | 4,000 | Call | Sole | 2020-05-15 | |
| 2020-03-31 | $1,953,160 | 4,000 | Put | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||